Enable Accessibility Enable Accessibility

About T-CiRA


Collaborative research aiming to develop innovative treatments over a 10-year period

T-CiRA is a joint research program by the Center for iPS Cell Research and Application (CiRA), Kyoto University and Takeda Pharmaceutical Company Limited. Over a 10-year period and under the direction of CiRA, this joint program will conduct research to develop clinical applications of iPS cells. We aim to develop innovative drugs and cell treatments in such areas as heart failure, diabetes mellitus, neuro-psychiatric disorders, cancer and intractable muscle diseases in order to fulfill the needs of patients promptly.

3logos.png

T-CiRA_logo.png

10year.png

200billion.png

10project.png

100man.png

Research area_E.png



button_pdf_E.png